Key result
Folic acid plus atorvastatin improves poststroke MoCA scores by ~0.5 points over placebo.
Why the study?
The study was conducted to evaluate the effects of atorvastatin combined with folic acid on poststroke cognitive impairment in patients with ischemic stroke using an optimized low-rank matrix denoising algorithm for MRI images.
Does folic acid combined with atorvastatin improve poststroke cognitive impairment (MOCA scores) and lower homocysteine and total cholesterol levels in patients with ischemic stroke?
RCT (n=64)
Placebo-controlled; two imaging physicians were blinded
Randomly divided into two groups (PSCI untreated group B and PSCI treated group C)
Does folic acid combined with atorvastatin improve poststroke cognitive impairment (MOCA scores) and lower homocysteine and total cholesterol levels in patients with ischemic stroke?
Folic acid combined with atorvastatin reduces homocysteine and total cholesterol levels and slows cognitive decline in patients with poststroke cognitive impairment, while GMM-based LRMD processing improves brain MRI image quality.
Answers are grounded in this paper and cite their sources.
Supports combined folic acid-atorvastatin to preserve cognition poststroke; extends RCT evidence on homocysteine and cholesterol reduction.
This research aimed to study the optimization effects of the low‐rank matrix denoising (LRMD) algorithm based on the Gaussian mixture model (GMM) on MRI images of stroke patients, aiming to evaluate the effects of atorvastatin combined with folic acid on poststroke cognitive impairment (PSCI) in patients with ischemic stroke. First, the GMM‐based low‐rank matrix denoising (LRMD) algorithm was constructed and applied to process MRI images of 64 patients with ischemic stroke. Then, the MRI images before and after processing were compared for the denoising degree and quality. An image with 5% noise was not as clear as an MRI image with 1% noise, and the effects of atorvastatin combined with folic acid on PSCI in patients with ischemic stroke were discussed. It was found that the denoising degree of MRI images processed by the GMM‐based LRMD algorithm was significantly improved, the image quality was significantly enhanced ( P < 0.05), and the diagnosis accuracy and efficiency of stroke patients were heightened. Atorvastatin combined with folic acid reduce the homocysteine (HCY) and total cholesterol (TC) levels, as well as Montreal Cognitive Scale (MOCA) scores of PSCI patients ( P < 0.05). In conclusion, the MRI images processed by the LRMD algorithm have good quality. Folic acid combined with atorvastatin can effectively reduce HCY and TC levels, thereby alleviating PSCI of stroke patients.
No takes yet. Share an insight, caveat, or question.
Li et al. (2022) conducted an RCT in Acute ischemic stroke with or without poststroke cognitive impairment (PSCI) (n=64). Folic acid combined with atorvastatin (plus GMM-based LRMD MRI algorithm) vs. Placebo treatment was evaluated on Montreal Cognitive Assessment (MOCA) score at 6 months (p=< 0.05). Folic acid combined with atorvastatin preserved MOCA scores and reduced homocysteine and total cholesterol in poststroke cognitive impairment.
Synapse has enriched 10 related papers. Consider them for comparative context: